EPO Patents = 3

Forward Citations = 24

Loading Chart...

8 inventors (with patents filed for the assignee):

Daniel R Getts (6 out of 21 patents)

Ryan Pearson (3 out of 4 patents)

Lonnie D Shea (2 out of 24 patents)

4. John Puisis (2 out of 4 patents)

5. James Herrmann (2 out of 2 patents)

6. Rachael Terry (1 out of 2 patents)

7. Nicholas King (1 out of 2 patents)

8. Frank Fokta (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 12502436 - Covalent polymer-antigen conjugated particles (2025-12-23),

2. 11510996 - Covalent polymer-antigen conjugated particles (2022-11-29),

3. 11484506 - Process for the preparation of tolerizing immune-modulating particles (2022-11-01),

4. 10471093 - Modified immune-modulating particles (2019-11-12),

5. 9919005 - Immune-modifying nanoparticles for the treatment of inflammatory diseases (2018-03-20),

6. 9913883 - Immune-modifying nanoparticles for the treatment of inflammatory diseases (2018-03-13),

Company Overview

Cour Pharmaceuticals Development Company, Inc. is a biopharmaceutical company focused on developing novel therapies for autoimmune diseases. The company's innovative approach combines cutting-edge drug delivery technology with a deep understanding of the immune system to create targeted treatments with improved efficacy and safety profiles. With a pipeline of promising drug candidates and a commitment to improving the lives of patients, Cour Pharmaceuticals is poised to make a significant impact in the field of autoimmune disease treatment.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#34 in Northbrook, IL

#2,112 in Illinois

#45,007 in US

Northbrook, IL, United States of America

Cour Pharmaceuticals Development Company, Inc.

Forward Citations = 24

8 inventors:

Daniel R Getts (6 out of 21 patents)

Ryan Pearson (3 out of 4 patents)

Lonnie D Shea (2 out of 24 patents)

4. John Puisis (2 out of 4 patents)

5. James Herrmann (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cour Pharmaceuticals Development Company, Inc.. Retrieved from https://idiyas.com/company/cour-pharmaceuticals-development-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]